iHear MatriX vs Resound Vivia 9 60S microRIE

The iHear MatriX is a behind-the-ear OTC hearing aid priced at $499, earning a B grade with a SoundScore of 3.8/5 in our lab testing. This places it in the top 40% of OTC hearing aids, offering solid performance at a budget-friendly price point. In our testing, the MatriX demonstrated notable strengths in speech intelligibility. Speech in quiet scored a solid 4.0/5, measuring 1.17 points above the category average. Speech in noise performance came in at 2.4/5—above the category average by 0.96 points, though only mixed in absolute terms. Feedback handling was excellent at 5.0/5, surpassing the already-strong category average by 0.46 points, meaning users can expect reliable stability without whistling during typical wear. The most significant limitation is music streaming, which scored 0.0/5—a full 1.92 points below the category average. Users who prioritize streaming audio from their phone should consider alternatives. Own-voice comfort measured 2.7/5, slightly above category average but still mixed in absolute terms. The MatriX features rechargeable batteries and supports streaming from both iPhone and Android devices. With a normalized Initial Score of 3.7/5 improving to 4.3/5 after tuning, this hearing aid responds well to optimization. It's best suited for users who prioritize speech clarity and feedback-free wear over music streaming quality, and who want a budget OTC option that delivers above-average speech performance in our lab framework.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.